ProCE Banner Activity

OUTBACK: Phase III Trial of CRT ± Adjuvant CT in Women With Locally Advanced Cervical Cancer

Slideset Download
Conference Coverage
In women with locally advanced cervical cancer, use of adjuvant carboplatin/paclitaxel after standard cisplatin-based CRT did not improve OS or PFS at 5 years.

Share

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Amgen, Inc.

AstraZeneca

Bristol Myers Squibb

Daiichi Sankyo, Inc.

Exelixis

Gilead Sciences, Inc.

GlaxoSmithKline

Ipsen Biopharmaceuticals Inc

Merck Sharp & Dohme Corp.

Novartis Pharmaceuticals Corporation

Pfizer, Inc.

Pharmacyclics LLC an AbbVie Company and Janssen Biotech Inc

Sanofi Genzyme